Form EFFECT Cidara Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 9, 2026 |
| Accession Number: | 0001193125-26-005782 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Next Shiba Inu Alternative? Remittix Brings a $0.28 PayFi Entry as Bitcoin’s Next Big Rally Remains in Focus
- Momcozy Expands Maternal Mental Health Resources With New Perinatal Support Guide
- CGTN: From 'potato capital' to 'token city': How a city in north China is transforming
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share